Search

Zoetis Inc

Закрыт

СекторЗдравоохранение

79.88 0.58

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

79.12

Макс.

79.93

Ключевые показатели

By Trading Economics

Доход

90M

691M

Продажи

206M

2.5B

P/E

Средняя по отрасли

13.12

51.78

Прибыль на акцию

1.87

Дивидендная доходность

2.58

Рентабельность продаж

27.998

Сотрудники

14,500

EBITDA

107M

1B

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+10.71% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

2.58%

1.96%

Дата следующей выплаты дивидендов

1 дек. 2026 г.

Следующая эксдивидендная дата

19 янв. 2027 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

2B

34B

Предыдущая цена открытия

79.3

Предыдущая цена закрытия

79.88

Zoetis Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

6 нояб. 2026 г., 23:06 UTC

Zoetis Inc shares are trading slightly lower in after-market hours, marking a third consecutive session of declines despite a smaller cumulative return.

5 нояб. 2026 г., 23:11 UTC

Zoetis Inc shares are modestly lower in after-market trading, reflecting broader market declines despite positive economic indicators released today.

4 нояб. 2026 г., 23:02 UTC

News

Zoetis proposes divesting certain assets in Australia, with a regulatory review expected to conclude in early 2027, according to an SEC filing.

2 нояб. 2026 г., 21:04 UTC

Zoetis Inc shares are advancing, breaking a trend of higher daily closes since Friday, despite a broader market experiencing a downward shift.

30 окт. 2026 г., 23:51 UTC

News

BTIG suspended its Buy rating on Zoetis Inc, contributing to a modest decline in the stock during after-market hours.

29 окт. 2026 г., 23:06 UTC

Zoetis Inc shares traded modestly lower in after-market hours, retracing from an initial slight rise to its opening level following Thursday's close.

28 окт. 2026 г., 23:06 UTC

In after-market trading, Zoetis Inc is effectively unchanged since Wednesday's close, remaining above its 20-day moving average and near the upper end of its one-month range.

27 окт. 2026 г., 23:06 UTC

News

UBS maintains Neutral rating on Zoetis Inc and raises price target to $85, following an announcement made after the market closed on Tuesday.

26 окт. 2026 г., 23:01 UTC

Zoetis Inc shares declined modestly in after-market trading, retracing from a brief peak and remaining lower than Monday's close.

23 окт. 2026 г., 19:56 UTC

Zoetis Inc shares fell sharply during Friday's trading session, reaching a notable low late morning.

22 окт. 2026 г., 20:07 UTC

Zoetis Inc shares are advancing, showing strong momentum and peaking around mid-afternoon, while remaining well above its 20-day moving average.

21 окт. 2026 г., 23:41 UTC

Zoetis Inc shares are trading modestly lower in after-market hours, following the broader market's significant decline.

20 окт. 2026 г., 22:02 UTC

News

Zoetis Inc. received FDA approval for Convenia RTU, an antibiotic for treating bacterial skin infections in dogs, set to launch in Q1 2027.

19 окт. 2026 г., 23:51 UTC

Zoetis Inc shares traded modestly lower in after-market hours, following a notable decline that has continued since Monday's close.

16 окт. 2026 г., 23:01 UTC

Zoetis Inc is trading lower in after-market hours, reflecting broader market declines amid stronger-than-expected inflation data and cautious sentiment on AI investments.

15 окт. 2026 г., 23:21 UTC

Zoetis Inc. has gained in after-market trading, reaching its highest cumulative return since Thursday's close, following a significant increase from a recent low.

14 окт. 2026 г., 19:36 UTC

Macro Event

Shares of Zoetis Inc are advancing amid key inflation reports, with a core inflation rate of 2.6% for September, slightly above expectations.

13 окт. 2026 г., 20:07 UTC

Zoetis Inc shares are declining, falling steadily after reaching a high at the market open.

12 окт. 2026 г., 20:06 UTC

Zoetis Inc shares are advancing, reaching their highest point of the day before market close and maintaining a position above the 20-day moving average.

10 окт. 2026 г., 00:01 UTC

Zoetis Inc. is declining in after-market trading, reversing recent gains and dropping below Friday's close.

9 окт. 2026 г., 23:30 UTC

Zoetis Inc declined in after-market trading, moving lower since Friday's close, contrasting with recent upward trends.

8 окт. 2026 г., 20:07 UTC

Zoetis Inc shares advanced, reflecting a notable increase since Wednesday's close, despite pulling back slightly from earlier session highs.

7 окт. 2026 г., 19:15 UTC

Zoetis Inc shares are modestly higher, peaking at nearly 0.94% intraday, maintaining a position around the middle of their one-month trading range.

6 окт. 2026 г., 23:05 UTC

Zoetis Inc's shares declined in after-market trading, remaining near the low end of its trading range since Tuesday's close.

5 окт. 2026 г., 21:02 UTC

Zoetis Inc. is trading modestly lower in after-market hours, experiencing unusual volatility and remaining below its 20-day moving average.

1 окт. 2026 г., 20:07 UTC

Zoetis Inc shares fell sharply, continuing a downward trend with four consecutive sessions of declines, closing well below its 20-day moving average.

30 сент. 2026 г., 20:02 UTC

Zoetis Inc shares fell sharply after an initial gain, currently trading below Tuesday's close and near the lower end of its one-month range.

29 сент. 2026 г., 20:07 UTC

Zoetis Inc shares are declining, reaching a low just before noon and trading well below their 20-day moving average.

28 сент. 2026 г., 22:01 UTC

Zoetis Inc. is trading modestly lower in after-market hours, continuing a downward trend with a cumulative return nearly 0.75% below Monday's close.

25 сент. 2026 г., 20:07 UTC

Zoetis Inc shares are trading higher amid overall market momentum, though they remain below their 20-day moving average and near the lower end of their one-month range.

Сравнение c конкурентами

Изменение цены

Zoetis Inc Прогноз

Целевая цена

By TipRanks

10.71% рост

Прогноз на 12 месяцев

Средняя 87.9 USD  10.71%

Максимум 115 USD

Минимум 74 USD

Основано на мнении 12 аналитиков Wall Street, спрогнозировавших целевые цены для Zoetis Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

12 ratings

4

Покупка

8

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat